Immupharma Plc On Track, Looking Good and Excited – 18th May 2017

Tim McCarthy talks to DirectorsTalk about its Lupuzor market update. Tim explains the main points to the update, the importance of reaching a milestone where all patients have been dosed for over three months, the importance of announcements to shareholders and confidence of providing top line results in Q1 2018.